about
Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingSelf-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer.Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast cancer: a case report and literature review.Chemosensitizing effect of podophyllotoxin acetate on topoisomerase inhibitors leads to synergistic enhancement of lung cancer cell apoptosisHerbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy.A simple method to improve the stability of docetaxel micellesPreclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform.Silicate esters of paclitaxel and docetaxel: synthesis, hydrophobicity, hydrolytic stability, cytotoxicity, and prodrug potential.Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.Immune regulation effect of lienal polypeptides extract in Lewis lung carcinoma-bearing mice treated with cyclophosphamide.Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines.Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes.Fish Oil Supplementation Enhances Pulmonary Strength and Endurance in Women Undergoing Chemotherapy.Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi.Mitochondria-targeted aggregation induced emission theranostics: crucial importance of activation
P2860
Q26778234-48A3EDCA-7438-426F-BAB9-59916F675EBCQ36219217-2C7596DF-91D2-4613-BF65-974072790F11Q36499095-340C6379-4334-45EE-AB6B-16DB0F00183AQ36892338-FD5FF363-5BC8-462F-87D9-E47850FBF3DCQ36959971-5BBBC14E-7A75-4A0E-B838-6FF749BAAAE2Q37408420-72E8BF34-BABA-42A5-8F90-C6AB7A27E516Q37502313-FF800EAC-1C3C-45BB-8185-755C5823AE5FQ37697357-C6CA7C05-1AA2-44D2-A258-9C34AFB27642Q37714105-13E58DD9-2CA0-47E6-88EF-89A10370AB25Q47594117-3A193DA2-FE0D-4BFB-B35B-09D2438BA0AAQ49657822-5D5B5E14-168A-432F-BBA8-FD51E3FD7D29Q50345931-BACC3771-5D56-4B74-B4A2-51BD72AA3812Q51502097-129FE6EA-9B1F-4E95-8220-2C317B08B2B3Q52590685-E6469D7B-2EEB-4BF2-BFFA-51474EA33879Q58374433-3F88E5DE-564D-4F90-8503-865E15149732
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Novel cytotoxic drugs: old challenges, new solutions.
@en
type
label
Novel cytotoxic drugs: old challenges, new solutions.
@en
prefLabel
Novel cytotoxic drugs: old challenges, new solutions.
@en
P2093
P1476
Novel cytotoxic drugs: old challenges, new solutions.
@en
P2093
Ahmad Awada
Daniela Dornelles Rosa
Gustavo F V Ismael
Max S Mano
P356
10.1016/J.CTRV.2007.08.001
P577
2007-10-01T00:00:00Z